BRISBANE, Calif. (AP) _ CareDx Inc. (CDNA) on Thursday reported a loss of $4.8 million in its fourth quarter.
The Brisbane, California-based company said it had a loss of 11 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 4 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.
The molecular diagnostics company posted revenue of $35.8 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $35.9 million.
For the year, the company reported that its loss narrowed to $22 million, or 52 cents per share. Revenue was reported as $127.1 million.
CareDx expects full-year revenue in the range of $165 million to $168 million.
CareDx shares have risen 4% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $22.45, a decrease of 29% in the last 12 months.